Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HOLMER ALAN F
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jenkins John Kenneth
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CATLIN AVERY W
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Salzmann Peter
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HOLMER ALAN F
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ben Yong
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jacques Rachelle Suzanne
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Altmeyer Anne
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Salzmann Peter
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HOLMER ALAN F
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jenkins John Kenneth
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jacques Rachelle Suzanne
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Altmeyer Anne
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ben Yong
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CATLIN AVERY W
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Sean F.
Corbus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(19.30%),Cormorant Global Healthcare GP, LLC(19.30%), etc.
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Smethurst Dominic
Corbus Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Smethurst Dominic
No Data